Bermudez LE et al. |
Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8067766
|
Uzun O et al. |
Efficacy of a three-day course of azithromycin in the treatment of community-acquired pneumococcal pneumonia. Preliminary report. |
1994 |
J Chemother |
pmid:8071680
|
Lang R et al. |
Therapeutic effects of roxithromycin and azithromycin in experimental murine brucellosis. |
1994 Jul-Aug |
Chemotherapy |
pmid:8082413
|
Eisenberg E and Barza M |
Azithromycin and clarithromycin. |
1994 |
Curr Clin Top Infect Dis |
pmid:8086122
|
Wynn RF et al. |
Azithromycin for cerebral toxoplasmosis in AIDS. |
1993 |
Lancet |
pmid:8093526
|
Bailey RL et al. |
Randomised controlled trial of single-dose azithromycin in treatment of trachoma. |
1993 |
Lancet |
pmid:8102427
|
Parent M |
[Initial empiric treatment of pneumonia and the new antibiotics]. |
1994 |
Union Med Can |
pmid:8109061
|
Saba J et al. |
Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8112357
|
Rodriguez WJ and Wiedermann BL |
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections. |
1994 |
Adv Pediatr Infect Dis |
pmid:8123221
|
Kanatani MS and Guglielmo BJ |
The new macrolides. Azithromycin and clarithromycin. |
1994 |
West. J. Med. |
pmid:8128699
|
Weber K et al. |
Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. |
1993 Nov-Dec |
Infection |
pmid:8132365
|
DÃaz Sánchez M et al. |
[New medications: azithromycin]. |
1993 Jul-Sep |
Rev Med Univ Navarra |
pmid:8134755
|
SteingrÃmsson O et al. |
Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. |
1994 Jan-Feb |
Sex Transm Dis |
pmid:8140488
|
Pfefferkorn ER and Borotz SE |
Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8141576
|
Bermudez LE et al. |
Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. |
1994 |
J. Infect. Dis. |
pmid:8158029
|
Bosatra A et al. |
[Effectiveness of and tolerance to azithromycin versus roxithromycin in the treatment of patients with acute infections of the upper respiratory tract]. |
1994 |
Clin Ter |
pmid:8168348
|
Kelsey JJ et al. |
Presence of azithromycin breast milk concentrations: a case report. |
1994 |
Am. J. Obstet. Gynecol. |
pmid:8178871
|
Spangler SK et al. |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192445
|
Stamler DA et al. |
Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192446
|
Mizukane R et al. |
Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203850
|
Marchi M et al. |
[Azithromycin-omeprazole. Treatment for the eradication of Helicobacter pylori]. |
1994 |
Minerva Gastroenterol Dietol |
pmid:8204705
|
Benson CA |
Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS. |
1994 |
Clin. Infect. Dis. |
pmid:8204776
|
Blais J et al. |
Inhibition of Toxoplasma gondii protein synthesis by azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215287
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Scaglione F et al. |
A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. |
1993 Nov-Dec |
Chemotherapy |
pmid:8222870
|
Braga PC and Piatti G |
Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells. |
1993 Nov-Dec |
Chemotherapy |
pmid:8222872
|
Weiss LM et al. |
Efficacy of azithromycin for treating Babesia microti infection in the hamster model. |
1993 |
J. Infect. Dis. |
pmid:8228366
|
Lefèvre JC et al. |
In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis. |
1993 |
Pathol. Biol. |
pmid:8233628
|
Agacfidan A et al. |
In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239579
|
Tomazic J et al. |
In vivo administration of azithromycin affects lymphocyte activity in vitro. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239585
|
Cantin L and Chamberland S |
In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239619
|
Fass RJ |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8257127
|
de Górgolas Hernández-Mora M et al. |
[Therapeutic approaches to cryptosporidiosis. A review of the literature]. |
1993 |
Rev Clin Esp |
pmid:8259458
|
Saverino D et al. |
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. |
1993 |
New Microbiol. |
pmid:8264424
|
Pajukanta R |
In vitro antimicrobial susceptibility of Porphyromonas gingivalis to azithromycin, a novel macrolide. |
1993 |
Oral Microbiol. Immunol. |
pmid:8265209
|
Gage TW |
New drugs from 1991-1992. |
1993 |
Tex Dent J |
pmid:8273018
|
Donowitz GR and Earnhardt KI |
Azithromycin inhibition of intracellular Legionella micdadei. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285604
|
Meyer AP et al. |
Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285612
|
Lalak NJ and Morris DL |
Azithromycin clinical pharmacokinetics. |
1993 |
Clin Pharmacokinet |
pmid:8287632
|
Godofsky EW |
Treatment of presumed cerebral toxoplasmosis with azithromycin. |
1994 |
N. Engl. J. Med. |
pmid:8302335
|
O'Connell S et al. |
Chronic active toxoplasmosis in an immunocompetent patient. |
1993 |
J. Infect. |
pmid:8308325
|
Berger BW |
Lyme disease. |
1993 |
Semin Dermatol |
pmid:8312152
|
Odugbemi T et al. |
Single oral dose of azithromycin for therapy of susceptible sexually transmitted diseases: a multicenter open evaluation. |
1993 Jul-Sep |
West Afr J Med |
pmid:8312208
|
Holdcroft C |
Two new macrolide antibiotics: clarithromycin and azithromycin. |
1993 |
Nurse Pract |
pmid:8380492
|
Spangler SK and Appelbaum PC |
Oxyrase, a method which avoids CO2 in the incubation atmosphere for anaerobic susceptibility testing of antibiotics affected by CO2. |
1993 |
J. Clin. Microbiol. |
pmid:8381817
|
Nahata MC et al. |
Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383944
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Brown ST et al. |
Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8384809
|
Cameron DJ |
Effectiveness of early Lyme disease treatment. |
1993 |
Am. J. Med. |
pmid:8388627
|
Hammerschlag MR et al. |
Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. |
1993 |
J. Pediatr. |
pmid:8388950
|
Melski JW et al. |
Primary and secondary erythema migrans in central Wisconsin. |
1993 |
Arch Dermatol |
pmid:8389536
|
Minguez F et al. |
In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria. |
1993 May-Jun |
Chemotherapy |
pmid:8389685
|
Bonnet M and Van der Auwera P |
Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390808
|
Gordillo ME et al. |
In vitro activity of azithromycin against bacterial enteric pathogens. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390813
|
Rodewald LE and Pichichero ME |
Compliance with antibiotic therapy: a comparison of deuterium oxide tracer, urine bioassay, bottle weights, and parental reports. |
1993 |
J. Pediatr. |
pmid:8391566
|
Vargas SL et al. |
Azithromycin for treatment of severe Cryptosporidium diarrhea in two children with cancer. |
1993 |
J. Pediatr. |
pmid:8391567
|
Gingras BA and Jensen JB |
Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. |
1993 |
Am. J. Trop. Med. Hyg. |
pmid:8394660
|
Mansoor GA et al. |
Azithromycin-induced acute interstitial nephritis. |
1993 |
Ann. Intern. Med. |
pmid:8395778
|
Guerra LG et al. |
Rapid response of AIDS-related bacillary angiomatosis to azithromycin. |
1993 |
Clin. Infect. Dis. |
pmid:8399879
|
Goldman MP and Longworth DL |
The role of azithromycin and clarithromycin in clinical practice. |
1993 Sep-Oct |
Cleve Clin J Med |
pmid:8403355
|
Fortner JH et al. |
Tapetal effect of an azalide antibiotic following oral administration in beagle dogs. |
1993 |
Fundam Appl Toxicol |
pmid:8405779
|
Narcio Reyes LE et al. |
[Efficacy and safety of azithromycin in the treatment of female genital Chlamydia trachomatis infections]. |
1993 |
Ginecol Obstet Mex |
pmid:8406112
|
Kobrehel G et al. |
9a,11-cyclic carbamates of 15-membered azalides. |
1993 |
J. Antibiot. |
pmid:8407586
|
Workowski KA et al. |
Azithromycin in chlamydial urethritis. |
1993 |
JAMA |
pmid:8411548
|
Genç M et al. |
An economic evaluation of screening for Chlamydia trachomatis in adolescent males. |
1993 |
JAMA |
pmid:8411572
|
Kuschner RA et al. |
Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. |
1995 |
Clin. Infect. Dis. |
pmid:8527539
|
Erdogru T et al. |
The treatment of non-gonococcal urethritis with single dose oral azithromycin. |
1995 Sep-Oct |
J. Int. Med. Res. |
pmid:8529783
|
Kieserman SP et al. |
Streptococcal pharyngitis: alternative treatments. |
1995 |
Ear Nose Throat J |
pmid:8536567
|
van Rijsoort-Vos JH et al. |
In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae. |
1995 |
J. Antimicrob. Chemother. |
pmid:8537268
|
Carbon C |
[Azithromycin: from macrolides to azalides]. |
1995 |
Pathol. Biol. |
pmid:8539067
|
|
[Special issue devoted to azithromycin]. |
1995 |
Pathol. Biol. |
pmid:8539068
|
Bergogne-Bérézin E |
[Azithromycin: tissue pharmacology]. |
1995 |
Pathol. Biol. |
pmid:8539071
|
Singlas E |
[Clinical pharmacokinetics of azithromycin]. |
1995 |
Pathol. Biol. |
pmid:8539072
|
Felstead S |
Azithromycin drug interactions. |
1995 |
Pathol. Biol. |
pmid:8539073
|
Modaï J |
[Azithromycin: clinical assessment]. |
1995 |
Pathol. Biol. |
pmid:8539076
|
Gehanno P |
[Use of azithromycin in ORL]. |
1995 |
Pathol. Biol. |
pmid:8539077
|
Leophonte P |
[Azithromycin and bronchopulmonary infections]. |
1995 |
Pathol. Biol. |
pmid:8539078
|
Micoud M and Pépin LF |
[Azithromycin and genital infections]. |
1995 |
Pathol. Biol. |
pmid:8539079
|
Coulaud JP |
[Azithromycin: new orientations]. |
1995 |
Pathol. Biol. |
pmid:8539080
|
Reinert P |
[Effects of azithromycin on the virulence of Pseudomonas aeruginosa]. |
1995 |
Pathol. Biol. |
pmid:8539081
|
Mégraud F et al. |
[Helicobacter pylori and azithromycin]. |
1995 |
Pathol. Biol. |
pmid:8539082
|
Derouin F |
[New pathogens and mode of action of azithromycin: Toxoplasma gondii]. |
1995 |
Pathol. Biol. |
pmid:8539083
|
Perronne C |
[Azithromycin and Mycobacterium avium infection]. |
1995 |
Pathol. Biol. |
pmid:8539084
|
Edelstein PH |
Review of azithromycin activity against Legionella spp. |
1995 |
Pathol. Biol. |
pmid:8539085
|
Tissi L et al. |
In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8540695
|
Oh YK et al. |
Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8540724
|
Amsden GW |
Macrolides versus azalides: a drug interaction update. |
1995 |
Ann Pharmacother |
pmid:8547740
|
Magid D et al. |
Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. |
1996 |
Ann. Intern. Med. |
pmid:8554247
|
Bauernfeind A et al. |
Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens. |
1995 Sep-Oct |
Infection |
pmid:8557398
|
Clancy J et al. |
Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase. |
1995 |
J. Antibiot. |
pmid:8557568
|
Martin DH et al. |
Comparison of azithromycin and ceftriaxone for the treatment of chancroid. |
1995 |
Clin. Infect. Dis. |
pmid:8562752
|
Amin NM and Breadon G |
An open-label, noncomparative study to evaluate the efficacy, safety, and tolerability of azithromycin in the treatment of patients with acute sinusitis. |
1995 Jul-Aug |
Clin Ther |
pmid:8565033
|
Principi N |
Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media. |
1995 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8565983
|
Strickman D et al. |
In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8585717
|
Kuzman I et al. |
Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study. |
1995 |
Scand. J. Infect. Dis. |
pmid:8588143
|
Bermudez LE et al. |
Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice. |
1995 |
J. Antimicrob. Chemother. |
pmid:8591938
|
Domingo S et al. |
Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice. |
1995 |
J. Antimicrob. Chemother. |
pmid:8591939
|
Nash KA and Inderlied CB |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8592991
|
Bohte R et al. |
Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593024
|
Bertoni G et al. |
Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. |
1996 |
Am. J. Gastroenterol. |
pmid:8607489
|